Table S2.
Group | BxPC-3
|
SW1990
|
||||
---|---|---|---|---|---|---|
Early apoptosis rate (%) | Late apoptosis rate (%) | Total apoptosis rate (%) | Early apoptosis (%) | Late apoptosis (%) | Total apoptosis (%) | |
Control | 4.71 ± 0.44 | 10.64 ± 1.16 | 15.35 ± 0.71 | 3.10 ± 0.41 | 9.41 ± 1.16 | 12.51 ± 0.97 |
NBMPR | 4.58 ± 0.35 | 10.90 ± 1.81 | 15.48 ± 1.55 | 3.06 ±0.21 | 9.46 ± 0.91 | 12.52 ± 0.73 |
GEM | 6.20 ± 0.94 | 19.23 ± 1.19 | 25.43 ± 1.69 | 7.22 ± 0.31 | 29.11 ± 1.31 | 36.33 ± 1.30 |
GEM + NBMPR | 4.18 ± 0.37 | 10.38 ± 0.86 | 14.56 ± 1.09 | 3.16 ± 0.37 | 10.61 ± 1.20 | 13.77 ± 0.93 |
GEM-C14 | 7.29 ± 0.94 | 19.60 ± 0.78 | 26.89 ± 1.19 | 8.15 ± 0.81 | 21.95 ± 2.15 | 30.10 ± 1.34 |
GEM-C14 + NBMPR | 8.49 ± 0.43 | 19.44 ± 1.88 | 27.93 ± 1.45 | 4.65 ± 1.19 | 21.33 ± 3.57 | 25.98 ± 2.41 |
GEM-HSA-NP | 7.55 ± 0.69 | 21.41 ± 1.10 | 28.96 ± 1.11 | 6.54 ± 1.51 | 24.48 ± 1.26 | 31.02 ± 1.72 |
GEM-HSA-NP + NBMPR | 8.78 ± 0.78 | 22.67 ± 0.78 | 31.45 ± 0.94 | 8.31 ± 0.97 | 24.73 ± 2.48 | 33.04 ± 1.59 |
Note: Data are expressed as mean ± SD.
Abbreviations: GEM, gemcitabine; GEM-C14, 4-N-myristoyl-gemcitabine; GEM-HSA-NP, gemcitabine-loaded human serum albumin nanoparticle; NBMPR, S-(4-nitrobenzyl)-6-thioinosine.